Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Commercial

Daiichi Sankyo shares slip after delaying annual earnings report

 April 24, 2026

BioSpace

Daiichi Sankyo’s full-year report was originally scheduled for April 27 but has now been pushed back to May 11.

CommercialRead full story

Post navigation

Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer →
← Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com